Characterization of the TCR β Chain CDR3 Repertoire in Subarachnoid Hemorrhage Patients with Delayed Cerebral Ischemia.
Bong Jun KimDong Hyuk YounYoungmi KimJin-Pyeong JeonPublished in: International journal of molecular sciences (2020)
Little is known of the adaptive immune response to subarachnoid hemorrhage (SAH). This study was the first to investigate whether T cell receptor (TCR) immune repertoire may provide a better understanding of T cell immunology in delayed cerebral ischemia (DCI). We serially collected peripheral blood in five SAH patients with DCI. High-throughput sequencing was used to analyze the TCR β chain (TCRB) complimentary determining regions (CDR) 3 repertoire. We evaluated the compositions and variations of the repertoire between admission and the DCI period, for severe DCI and non-severe DCI patients. Clonality did not differ significantly between admission and DCI. Severe DCI patients had significantly lower clonality than non-severe DCI patients (p value = 0.019). A read frequency of 0.005% ≤ - < 0.05% dominated the clonal expansion in non-severe DCI patients. Regarding repertoire diversity, severe DCI had a higher diversity score on admission than non-severe DCI. The CDR3 lengths were similar between admission and DCI. Among 728 annotated V-J gene pairs, we found that the relative frequencies of two V-J pairs were different at the occurrence of DCI than at admission, with T cells increasing by over 15%. TCRB CDR3 repertoires may serve as biomarkers to identify severe DCI patients.
Keyphrases
- subarachnoid hemorrhage
- end stage renal disease
- cerebral ischemia
- chronic kidney disease
- ejection fraction
- newly diagnosed
- emergency department
- brain injury
- early onset
- peritoneal dialysis
- peripheral blood
- high throughput sequencing
- blood brain barrier
- dna methylation
- risk assessment
- patient reported outcomes
- immune response
- single molecule
- transcription factor
- dendritic cells
- genome wide